83 related articles for article (PubMed ID: 14742629)
1. An expansion in the ZNF9 gene causes PROMM in a previously described family with an incidental CLCN1 mutation.
Lamont PJ; Jacob RL; Mastaglia FL; Laing NG
J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):343. PubMed ID: 14742629
[No Abstract] [Full Text] [Related]
2. Clinical and genetic analysis of a family with PROMM.
Grewal RP; Zhang S; Ma W; Rosenberg M; Krahe R
J Clin Neurosci; 2004 Aug; 11(6):603-5. PubMed ID: 15261229
[TBL] [Abstract][Full Text] [Related]
3. Myotonia congenita and myotonic dystrophy in the same family: coexistence of a CLCN1 mutation and expansion in the CNBP (ZNF9) gene.
Sun C; Van Ghelue M; Tranebjærg L; Thyssen F; Nilssen Ø; Torbergsen T
Clin Genet; 2011 Dec; 80(6):574-80. PubMed ID: 21204798
[TBL] [Abstract][Full Text] [Related]
4. Severe dilated cardiomyopathy in a patient with myotonic dystrophy type 2 and homozygous repeat expansion in ZNF9.
Lee TM; Maurer MS; Karbassi I; Braastad C; Batish SD; Chung WK
Congest Heart Fail; 2012; 18(3):183-6. PubMed ID: 22587749
[No Abstract] [Full Text] [Related]
5. Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2.
Cardani R; Giagnacovo M; Botta A; Rinaldi F; Morgante A; Udd B; Raheem O; Penttilä S; Suominen T; Renna LV; Sansone V; Bugiardini E; Novelli G; Meola G
J Neurol; 2012 Oct; 259(10):2090-9. PubMed ID: 22407275
[TBL] [Abstract][Full Text] [Related]
6. PROMM and deafness: exclusion of ZNF9 as the disease gene in DFNA18 suggests a polygenic origin of the PROMM/DM2 phenotype.
Bönsch D; Neumann C; Lang-Roth R; Witte O; Lamprecht-Dinnesen A; Deufel T
Clin Genet; 2003 Jan; 63(1):73-5. PubMed ID: 12519376
[No Abstract] [Full Text] [Related]
7. Improvement of the diagnostic procedure in proximal myotonic myopathy/myotonic dystrophy type 2.
Jakubiczka S; Vielhaber S; Kress W; Küpferling P; Reuner U; Kunath B; Wieacker P
Neurogenetics; 2004 Feb; 5(1):55-9. PubMed ID: 14666402
[TBL] [Abstract][Full Text] [Related]
8. Does proximal myotonic myopathy show anticipation?
Kruse B; Wöhrle D; Steinbach P; Gal A
Hum Mutat; 2008 Aug; 29(8):E100-2. PubMed ID: 18484632
[TBL] [Abstract][Full Text] [Related]
9. Myotonic dystrophy type 2 is rare in the Japanese population.
Matsuura T; Minami N; Arahata H; Ohno K; Abe K; Hayashi YK; Nishino I
J Hum Genet; 2012 Mar; 57(3):219-20. PubMed ID: 22258159
[No Abstract] [Full Text] [Related]
10. Haploinsuffciency for Znf9 in Znf9+/- mice is associated with multiorgan abnormalities resembling myotonic dystrophy.
Chen W; Wang Y; Abe Y; Cheney L; Udd B; Li YP
J Mol Biol; 2007 Apr; 368(1):8-17. PubMed ID: 17335846
[TBL] [Abstract][Full Text] [Related]
11. [Molecular and genetic aspects of the myotonic conditions].
Morales Montero F; Cuenca Berger P
Rev Neurol; 2004 Apr 1-15; 38(7):668-74. PubMed ID: 15098190
[TBL] [Abstract][Full Text] [Related]
12. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24.
Le Ber I; Martinez M; Campion D; Laquerrière A; Bétard C; Bassez G; Girard C; Saugier-Veber P; Raux G; Sergeant N; Magnier P; Maisonobe T; Eymard B; Duyckaerts C; Delacourte A; Frebourg T; Hannequin D
Brain; 2004 Sep; 127(Pt 9):1979-92. PubMed ID: 15215218
[TBL] [Abstract][Full Text] [Related]
13. Effect of the [CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy type II (DM2).
Botta A; Caldarola S; Vallo L; Bonifazi E; Fruci D; Gullotta F; Massa R; Novelli G; Loreni F
Biochim Biophys Acta; 2006 Mar; 1762(3):329-34. PubMed ID: 16376058
[TBL] [Abstract][Full Text] [Related]
14. A family with PROMM not linked to the recently mapped PROMM locus DM2.
Wieser T; Bönsch D; Eger K; Schulte-Mattler W; Zierz S
Neuromuscul Disord; 2000 Feb; 10(2):141-3. PubMed ID: 10714590
[TBL] [Abstract][Full Text] [Related]
15. Type 2 myotonic dystrophy can be predicted by the combination of type 2 muscle fiber central nucleation and scattered atrophy.
Bassez G; Chapoy E; Bastuji-Garin S; Radvanyi-Hoffman H; Authier FJ; Pellissier JF; Eymard B; Gherardi RK
J Neuropathol Exp Neurol; 2008 Apr; 67(4):319-25. PubMed ID: 18379436
[TBL] [Abstract][Full Text] [Related]
16. Unusual clinical, laboratory, and muscle histopathological findings in a family with myotonic dystrophy type 2.
Toth C; Dunham C; Suchowersky O; Parboosingh J; Brownell K
Muscle Nerve; 2007 Feb; 35(2):259-64. PubMed ID: 17068784
[TBL] [Abstract][Full Text] [Related]
17. Muscleblind-like 2 (Mbnl2) -deficient mice as a model for myotonic dystrophy.
Hao M; Akrami K; Wei K; De Diego C; Che N; Ku JH; Tidball J; Graves MC; Shieh PB; Chen F
Dev Dyn; 2008 Feb; 237(2):403-10. PubMed ID: 18213585
[TBL] [Abstract][Full Text] [Related]
18. Eosinophilic myositis as first manifestation in a patient with type 2 myotonic dystrophy CCTG expansion mutation and rheumatoid arthritis.
Meyer A; Lannes B; Carapito R; Bahram S; Echaniz-Laguna A; Geny B; Sibilia J; Gottenberg JE
Neuromuscul Disord; 2015 Feb; 25(2):149-52. PubMed ID: 25443993
[TBL] [Abstract][Full Text] [Related]
19. Report of the 115th ENMC workshop: DM2/PROMM and other myotonic dystrophies. 3rd Workshop, 14-16 February 2003, Naarden, The Netherlands.
Udd B; Meola G; Krahe R; Thornton C; Ranum L; Day J; Bassez G; Ricker K
Neuromuscul Disord; 2003 Sep; 13(7-8):589-96. PubMed ID: 12921797
[No Abstract] [Full Text] [Related]
20. Comparative efficacy of repetitive nerve stimulation, exercise, and cold in differentiating myotonic disorders.
Michel P; Sternberg D; Jeannet PY; Dunand M; Thonney F; Kress W; Fontaine B; Fournier E; Kuntzer T
Muscle Nerve; 2007 Nov; 36(5):643-50. PubMed ID: 17654559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
